 | • レポートコード：GIR201113706 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、バイオ医薬品及びワクチンの世界市場を調査対象にし、バイオ医薬品及びワクチンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（バイオ医薬品、ワクチン製造）、用途別分析（製薬産業、臨床診断、科学研究、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Novartis、Alexion Pharmaceuticals、Roche、Pfizer、Regeneron Pharmaceuticals、Sanofi、GlaxoSmithKline、Biogen Idec、Abbott、Johnson and Johnson、Merck、Rentschler、Lonza、Boehringer Ingelheim ・企業別売上、市場シェア ・バイオ医薬品及びワクチンの地域別市場分析 ・バイオ医薬品及びワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・バイオ医薬品及びワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・バイオ医薬品及びワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・バイオ医薬品及びワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・バイオ医薬品及びワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・バイオ医薬品及びワクチンの種類別市場規模2015-2020：バイオ医薬品、ワクチン製造 ・バイオ医薬品及びワクチンの用途別市場規模2015-2020：製薬産業、臨床診断、科学研究、その他 ・バイオ医薬品及びワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Biopharmaceutical and Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biopharmaceutical and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biopharmaceutical and Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceutical and Vaccines market has been segmented into:
Biopharmaceutical
Vaccine Production
By Application, Biopharmaceutical and Vaccines has been segmented into:
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical and Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical and Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical and Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical and Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharmaceutical and Vaccines Market Share Analysis
Biopharmaceutical and Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical and Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical and Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceutical and Vaccines are:
Novartis
Alexion Pharmaceuticals
Roche
Pfizer
Regeneron Pharmaceuticals
Sanofi
GlaxoSmithKline
Biogen Idec
Abbott
Johnson and Johnson
Merck
Rentschler
Lonza
Boehringer Ingelheim
1 Biopharmaceutical and Vaccines Market Overview
1.1 Product Overview and Scope of Biopharmaceutical and Vaccines
1.2 Classification of Biopharmaceutical and Vaccines by Type
1.2.1 Global Biopharmaceutical and Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2019
1.2.3 Biopharmaceutical
1.2.4 Vaccine Production
1.3 Global Biopharmaceutical and Vaccines Market by Application
1.3.1 Overview: Global Biopharmaceutical and Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceuticals Industry
1.3.3 Clinical Diagnosis
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Biopharmaceutical and Vaccines Market by Regions
1.4.1 Global Biopharmaceutical and Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceutical and Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceutical and Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical and Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical and Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceutical and Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical and Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Alexion Pharmaceuticals
2.2.1 Alexion Pharmaceuticals Details
2.2.2 Alexion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Alexion Pharmaceuticals SWOT Analysis
2.2.4 Alexion Pharmaceuticals Product and Services
2.2.5 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Regeneron Pharmaceuticals
2.5.1 Regeneron Pharmaceuticals Details
2.5.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Regeneron Pharmaceuticals SWOT Analysis
2.5.4 Regeneron Pharmaceuticals Product and Services
2.5.5 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biogen Idec
2.8.1 Biogen Idec Details
2.8.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biogen Idec SWOT Analysis
2.8.4 Biogen Idec Product and Services
2.8.5 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson and Johnson
2.10.1 Johnson and Johnson Details
2.10.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson and Johnson SWOT Analysis
2.10.4 Johnson and Johnson Product and Services
2.10.5 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck SWOT Analysis
2.11.4 Merck Product and Services
2.11.5 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.12 Rentschler
2.12.1 Rentschler Details
2.12.2 Rentschler Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Rentschler SWOT Analysis
2.12.4 Rentschler Product and Services
2.12.5 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.13 Lonza
2.13.1 Lonza Details
2.13.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Lonza SWOT Analysis
2.13.4 Lonza Product and Services
2.13.5 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.14 Boehringer Ingelheim
2.14.1 Boehringer Ingelheim Details
2.14.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Boehringer Ingelheim SWOT Analysis
2.14.4 Boehringer Ingelheim Product and Services
2.14.5 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceutical and Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical and Vaccines Players Market Share
3.2.2 Top 10 Biopharmaceutical and Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceutical and Vaccines Revenue and Market Share by Regions
4.2 North America Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceutical and Vaccines Revenue by Countries
5.1 North America Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
5.2 USA Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceutical and Vaccines Revenue by Countries
6.1 Europe Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
7.2 China Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceutical and Vaccines Revenue by Countries
8.1 South America Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceutical and Vaccines by Countries
9.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceutical and Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical and Vaccines Market Forecast by Type (2019-2024)
10.3 Biopharmaceutical Revenue Growth Rate (2015-2025)
10.4 Vaccine Production Revenue Growth Rate (2015-2025)
11 Global Biopharmaceutical and Vaccines Market Segment by Application
11.1 Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceutical and Vaccines Market Forecast by Application (2019-2024)
11.3 Pharmaceuticals Industry Revenue Growth (2015-2020)
11.4 Clinical Diagnosis Revenue Growth (2015-2020)
11.5 Scientific Research Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Biopharmaceutical and Vaccines Market Size Forecast (2021-2025)
12.1 Global Biopharmaceutical and Vaccines Market Size Forecast (2021-2025)
12.2 Global Biopharmaceutical and Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceutical and Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Biopharmaceutical and Vaccines Major Business
Table 7. Novartis Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Biopharmaceutical and Vaccines Product and Solutions
Table 10. Novartis Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Alexion Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Major Business
Table 13. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Alexion Pharmaceuticals SWOT Analysis
Table 15. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 16. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Biopharmaceutical and Vaccines Major Business
Table 19. Roche Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Biopharmaceutical and Vaccines Product and Solutions
Table 22. Roche Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Biopharmaceutical and Vaccines Major Business
Table 25. Pfizer Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Biopharmaceutical and Vaccines Product and Solutions
Table 28. Pfizer Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Regeneron Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Major Business
Table 31. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Regeneron Pharmaceuticals SWOT Analysis
Table 33. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 34. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Biopharmaceutical and Vaccines Major Business
Table 37. Sanofi Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Biopharmaceutical and Vaccines Product and Solutions
Table 40. Sanofi Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. GlaxoSmithKline Corporate Information, Location and Competitors
Table 42. GlaxoSmithKline Biopharmaceutical and Vaccines Major Business
Table 43. GlaxoSmithKline Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. GlaxoSmithKline SWOT Analysis
Table 45. GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
Table 46. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Biogen Idec Corporate Information, Location and Competitors
Table 48. Biogen Idec Biopharmaceutical and Vaccines Major Business
Table 49. Biogen Idec Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. Biogen Idec SWOT Analysis
Table 51. Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
Table 52. Biogen Idec Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Corporate Information, Location and Competitors
Table 54. Abbott Biopharmaceutical and Vaccines Major Business
Table 55. Abbott Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. Abbott SWOT Analysis
Table 57. Abbott Biopharmaceutical and Vaccines Product and Solutions
Table 58. Abbott Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Johnson and Johnson Corporate Information, Location and Competitors
Table 60. Johnson and Johnson Biopharmaceutical and Vaccines Major Business
Table 61. Johnson and Johnson Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 62. Johnson and Johnson SWOT Analysis
Table 63. Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
Table 64. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Merck Corporate Information, Location and Competitors
Table 66. Merck Biopharmaceutical and Vaccines Major Business
Table 67. Merck Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 68. Merck SWOT Analysis
Table 69. Merck Biopharmaceutical and Vaccines Product and Solutions
Table 70. Merck Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Rentschler Corporate Information, Location and Competitors
Table 72. Rentschler Biopharmaceutical and Vaccines Major Business
Table 73. Rentschler Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 74. Rentschler SWOT Analysis
Table 75. Rentschler Biopharmaceutical and Vaccines Product and Solutions
Table 76. Rentschler Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Lonza Corporate Information, Location and Competitors
Table 78. Lonza Biopharmaceutical and Vaccines Major Business
Table 79. Lonza Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 80. Lonza SWOT Analysis
Table 81. Lonza Biopharmaceutical and Vaccines Product and Solutions
Table 82. Lonza Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 84. Boehringer Ingelheim Biopharmaceutical and Vaccines Major Business
Table 85. Boehringer Ingelheim Biopharmaceutical and Vaccines Total Revenue (USD Million) (2017-2018)
Table 86. Boehringer Ingelheim SWOT Analysis
Table 87. Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
Table 88. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Biopharmaceutical and Vaccines Revenue (Million USD) by Players (2015-2020)
Table 90. Global Biopharmaceutical and Vaccines Revenue Share by Players (2015-2020)
Table 91. Global Biopharmaceutical and Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Biopharmaceutical and Vaccines Revenue Market Share by Regions (2015-2020)
Table 93. North America Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
Table 94. North America Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Table 95. Europe Biopharmaceutical and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Biopharmaceutical and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Biopharmaceutical and Vaccines Revenue by Countries (2015-2020)
Table 98. South America Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Biopharmaceutical and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Table 101. Global Biopharmaceutical and Vaccines Revenue (Million USD) by Type (2015-2020)
Table 102. Global Biopharmaceutical and Vaccines Revenue Share by Type (2015-2020)
Table 103. Global Biopharmaceutical and Vaccines Revenue Forecast by Type (2021-2025)
Table 104. Global Biopharmaceutical and Vaccines Revenue by Application (2015-2020)
Table 105. Global Biopharmaceutical and Vaccines Revenue Share by Application (2015-2020)
Table 106. Global Biopharmaceutical and Vaccines Revenue Forecast by Application (2021-2025)
Table 107. Global Biopharmaceutical and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceutical and Vaccines Picture
Figure 2. Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2019
Figure 3. Biopharmaceutical Picture
Figure 4. Vaccine Production Picture
Figure 5. Biopharmaceutical and Vaccines Revenue Market Share by Application in 2019
Figure 6. Pharmaceuticals Industry Picture
Figure 7. Clinical Diagnosis Picture
Figure 8. Scientific Research Picture
Figure 9. Others Picture
Figure 10. Global Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biopharmaceutical and Vaccines Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Biopharmaceutical and Vaccines Revenue Market Share in 2019
Figure 19. Global Top 10 Players Biopharmaceutical and Vaccines Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Biopharmaceutical and Vaccines Revenue Market Share by Regions (2015-2020)
Figure 23. Global Biopharmaceutical and Vaccines Revenue Market Share by Regions in 2018
Figure 24. North America Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Europe Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. South America Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. North America Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 30. North America Biopharmaceutical and Vaccines Revenue Market Share by Countries in 2019
Figure 31. USA Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Canada Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 34. Europe Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Biopharmaceutical and Vaccines Revenue Market Share by Countries in 2019
Figure 36. Germany Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. UK Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. France Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Russia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Italy Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Share by Countries in 2019
Figure 43. China Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Japan Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. Korea Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. India Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. South America Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 49. South America Biopharmaceutical and Vaccines Revenue Market Share by Countries in 2019
Figure 50. Brazil Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. UAE Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Biopharmaceutical and Vaccines Revenue and Growth Rate (2015-2020)
Figure 58. Global Biopharmaceutical and Vaccines Revenue Share by Type (2015-2020)
Figure 59. Global Biopharmaceutical and Vaccines Revenue Share by Type in 2019
Figure 60. Global Biopharmaceutical and Vaccines Market Share Forecast by Type (2021-2025)
Figure 61. Global Biopharmaceutical Revenue Growth Rate (2015-2020)
Figure 62. Global Vaccine Production Revenue Growth Rate (2015-2020)
Figure 63. Global Biopharmaceutical and Vaccines Revenue Share by Application (2015-2020)
Figure 64. Global Biopharmaceutical and Vaccines Revenue Share by Application in 2019
Figure 65. Global Biopharmaceutical and Vaccines Market Share Forecast by Application (2021-2025)
Figure 66. Global Pharmaceuticals Industry Revenue Growth Rate (2015-2020)
Figure 67. Global Clinical Diagnosis Revenue Growth Rate (2015-2020)
Figure 68. Global Scientific Research Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Biopharmaceutical and Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Biopharmaceutical and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Biopharmaceutical and Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
Figure 74. Europe Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
Figure 76. South America Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
バイオ医薬品及びワクチン生産の世界市場 2020年 Market Overview The global Biopharmaceutical and Vaccine Production market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biop…- バイオ医薬品ドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioph…
- バイオ医薬品ドラッグデリバリー技術の世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- バイオ医薬品添加剤の世界市場 2020年 Market Overview The global Biopharmaceutical Excipients market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biopharmaceutica…
- バイオ医薬品受託製造（BCMO）の世界市場 2020年 Market Overview The global Biopharmaceutical Contract Manufacturing(BCMO) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…